Omnicell OMCL
NASDAQ OMCL
$34.37 -0.45 (-1.29%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omnicell (OMCL) Total Non-Current Liabilities (2010 - 2026)

Omnicell's (OMCL) quarterly Total Non-Current Liabilities came in at $696.1 million in Q2 2026, down 20.35% year-over-year from $873.9 million in Q2 2025, and down 5.59% quarter-over-quarter from $737.3 million in Q1 2026.

Analysis

Omnicell (OMCL) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Omnicell (OMCL) has reported Total Non-Current Liabilities for 17 consecutive years, with $696.1 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 20.35% year-over-year to $696.1 million in Q2 2026; TTM through Jun 2026 was $696.1 million, a 20.35% decrease from a year earlier, with the FY2025 full-year figure at $732.9 million, down 15.8% from the prior year.
  • Total Non-Current Liabilities was $696.1 million for Q2 2026 at Omnicell, down from $737.3 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $1.1 billion in Q1 2023 and troughed at $696.1 million in Q2 2026.
  • A 5-year average of $950.9 million and a median of $1.0 billion in 2022 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities gained 21.4% in 2022 and tumbled 32.4% in 2025, its largest moves.
  • Over 5 years, Total Non-Current Liabilities stood at $1.1 billion in 2022, then declined by 3.94% to $1.0 billion in 2023, then slipped by 15.62% to $870.4 million in 2024, then dropped by 15.8% to $732.9 million in 2025, then slipped by 5.02% to $696.1 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $696.1 million (Q2 2026), $737.3 million (Q1 2026), and $732.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 1.92 Bn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 40.46 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 21.28 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 17.56 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 2.57 Bn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn 6.34 Bn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 3.68 Bn
9 Resmed 32.94 Bn 31.47 Bn 861.22 Mn 985.45 Mn
10 Omnicell 1.57 Bn 1.28 Bn 152.94 Mn 696.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 696.11 Mn
Mar 31, 2026 737.31 Mn
Dec 31, 2025 732.94 Mn
Sep 30, 2025 719.47 Mn
Jun 30, 2025 873.91 Mn
Mar 31, 2025 886.79 Mn
Dec 31, 2024 870.43 Mn
Sep 30, 2024 1.06 Bn
Jun 30, 2024 1.08 Bn
Mar 31, 2024 1.09 Bn
Dec 31, 2023 1.03 Bn
Sep 30, 2023 1.03 Bn
Jun 30, 2023 1.02 Bn
Mar 31, 2023 1.10 Bn
Dec 31, 2022 1.07 Bn
Sep 30, 2022 1.04 Bn
Jun 30, 2022 1.03 Bn
Mar 31, 2022 1.04 Bn
Dec 31, 2021 987.97 Mn
Sep 30, 2021 929.37 Mn